The Gastroenterologist's Insider Guide to GLP-1 Agonists: From Semaglutide to Tirzepatide Jan 25, 2025 4 min read As a gastroenterologist, I'm excited to share the latest developments in GLP-1 agonists and their impact on obesity-related gastrointestinal complications
If pain persists longer than two weeks, worsens, or becomes recurrent, its time to seek professional help
Patients should be counselled that Wegovy is not a permanent solution
Glutathione is widely recognized for its antioxidant and antimelanogenesis properties, and this study investigated its potential as a depigmenting agent
Latest Advances in Diabetes Treatments and Market Expansion The diabetes drug pipeline is equally dynamic
Interestingly, fat depletion completely reversed the intestinal expression of GST-4::GFP in all sterile worms, including the faint expression in WT worms (Supplementary Figs